Sen. Susan M. Collins bought Teleflex (TFX)
Sen. Susan M. Collins (R-ME) · $15K–$50K · traded Nov 10, 2014
- Transaction
- Bought
- Amount
- $15K–$50K
- Owner
- Spouse
- Traded
- Nov 10, 2014
- Disclosed
- Dec 1, 2014
- Days to disclose
- 21
- Asset type
- Stock
- As filed
- Teleflex Incorporated (NYSE)
- Industry
- Medical - Instruments & Supplies · Healthcare
Other trades in this filing
All of Collins's trades →- Dec 1, 2014$15K–$50K
Bought Precision Castparts PCP
$15K–$50K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
- Dec 1, 2014$1K–$15K
$1K–$15K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
- Dec 1, 2014$1K–$15K
$1K–$15K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
- Dec 1, 2014$1K–$15K
Sold (full) Texas Instruments TXN
$1K–$15K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
Got $7K from the company’s PAC - Dec 1, 2014$1K–$15K
$1K–$15K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
Got $8K from the company’s PAC - Dec 1, 2014$1K–$15K
Sold (full) Alerian MLP ETF AMLP
$1K–$15K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
- Dec 1, 2014$1K–$15K
$1K–$15K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
- Dec 1, 2014$1K–$15K
$1K–$15K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
- Dec 1, 2014$1K–$15K
$1K–$15K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
- Dec 1, 2014$1K–$15K
$1K–$15K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
- Dec 1, 2014$1K–$15K
$1K–$15K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
- Dec 1, 2014$1K–$15K
$1K–$15K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
- Dec 1, 2014$15K–$50K
$15K–$50K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
- Dec 1, 2014$1K–$15K
Sold (full) Raytheon Company (NYSE) RTN
$1K–$15K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
- Dec 1, 2014$1K–$15K
$1K–$15K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
- Dec 1, 2014$15K–$50K
$15K–$50K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
- Dec 1, 2014$1K–$15K
$1K–$15K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
- Dec 1, 2014$1K–$15K
$1K–$15K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
Got $8K from the company’s PAC - Dec 1, 2014$15K–$50K
$15K–$50K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
- Dec 1, 2014$50K–$100K
Sold (full) MainStay Marketfield C (NASDAQ) MFCDX
$50K–$100K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
Recent Congress trades in TFX
- Aug 13, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
- Aug 13, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Jul 16, 2025 · disclosed Aug 13, 2025 · Spouse
- Mar 27, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded Feb 25, 2025 · disclosed Mar 27, 2025
- Nov 8, 2023$1K–$15K
- Aug 13, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
$15K–$50K · Traded Jul 12, 2023 · disclosed Aug 13, 2023
- May 19, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
$15K–$50K · Traded Apr 10, 2023 · disclosed May 19, 2023
Company context for TFX
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
TFX: third_quarter 2026 lobbying report
Issues related to medical device tariffs. Issues related to physician reimbursement, prior authorization, breakthrough medical devices, and obesity treatments.
Public: Oct 19, 2026, 2:14 PM EDTOriginal source ↗TFX: third_quarter 2026 lobbying report
Educated key government stakeholders on Teleflexs research and development capabilities in support of US Service members. Educated key government stakeholders on Teleflexs research and development capabilities in support of US Service members.
Public: Oct 8, 2026, 3:05 PM EDTOriginal source ↗TFX: second_quarter 2026 lobbying report
Issues related to physician reimbursement, prior authorization, breakthrough medical devices, and obesity treatments. Issues related to medical device tariffs.
Public: Jul 20, 2026, 4:43 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.